Pure Extracts Technologies (PULL.C) set their milestone timetable for their study on both the formulation and manufacturing of psilocybin-based treatments today, according to a press release. The study’s focus…
Canadian Good Manufacturing Practice
Pure Extracts Technologies (PULL.C) commenced a study on the formulation and manufacturing of psilocybin-based treatments today, according to a press release. The products will come as oral tablets, capsules…